Clinical Trial ID: NCT04384484
A Phase 3 Randomized Study of Loncastuximab Tesirine Combined with Rituximab Versus Immunochemotherapy in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL) (LOTIS-5)
Status
Open
Conditions
Other
Phases
III
Age Group
Adult
Main Investiagtor
Norkin, Maxim
Practice
Lymphoma
Scope
National
Participating Institutions
Baptist MD Anderson Cancer Center
Nct ID Number
NCT04384484
Secondary Trial ID Number
ADCT 402-311; ADCT-402-311
Keywords
Treatment